Acellular Dermal Matrix vs Autologous Tarsus for Correction of Lower Eyelid Retraction
Recruiting
N/A
Interventional Study
Lower Eyelid Retraction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Haukeland University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the effectiveness of two promising implants in treatment of lower eyelid retraction in 40 patients. This condition often resulting from injury, surgical complications, or thyroid eye disease. The main questions it aims to answer are:
Which implant provides better long-term stability of the eyelid malposition?
Does one implant minimize complications a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients aged 18-75 years.
* Grade 2 or higher lower eyelid retraction (according to the retraction grading scale).
* Candidate for surgical correction due to functional or cosmetic reasons.
* Willingness to participate and provide informed consent.
Exclusion Criteria:
…
Contacts